AAV-BDNF augments neurogenesis in both the normal adult rat brain and the quinolinic acid lesion model of Huntington's disease

被引：0
|
作者：
Connor, B
Henry, RA
Faull, RLM
Hughes, SM
机构：
[1] Univ Auckland, Dept Pharmacol & Clin Pharmacol, Fac Med & Hlth Sci, Auckland 1, New Zealand
[2] Univ Auckland, Dept Anat & Radiol, Fac Med & Hlth Sci, Auckland 1, New Zealand
来源：
EXPERIMENTAL NEUROLOGY | 2006年 / 198卷 / 02期
关键词：
D O I：
10.1016/j.expneurol.2006.02.033
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：565 / 565
页数：1
相关论文
共 50 条
  • [21] Adenosine A2A antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington's disease
    Gianfriddo, M
    Corsi, C
    Melani, A
    Pèzzola, A
    Reggio, R
    Popoli, P
    Pedata, F
    BRAIN RESEARCH, 2003, 979 (1-2) : 225 - 229
  • [22] Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: A potential novel treatment in a rat model of Huntington's disease
    Joel, D
    Ayalon, L
    Tarrasch, R
    Weiner, I
    MOVEMENT DISORDERS, 2003, 18 (12) : 1499 - 1507
  • [23] Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease
    Giampa, Carmela
    Patassini, Stefano
    Borreca, Antonella
    Laurenti, Daunia
    Marullo, Fabrizia
    Bernardi, Giorgio
    Menniti, Frank S.
    Fusco, Francesca R.
    NEUROBIOLOGY OF DISEASE, 2009, 34 (03) : 450 - 456
  • [24] Quinolinic acid released from polymeric brain implants causes behavioral and neuroanatomical alterations in a rodent model of Huntington's disease
    Haik, KL
    Shear, DA
    Schroeder, U
    Sabel, BA
    Dunbar, GL
    EXPERIMENTAL NEUROLOGY, 2000, 163 (02) : 430 - 439
  • [25] An Optimization of AAV-82Q-Delivered Rat Model of Huntington's Disease
    So, Kyoung-Ha
    Choi, Jai Ho
    Islam, Jaisan
    Elina, K. C.
    Moon, Hyeong Cheol
    Won, So Yoon
    Kim, Hyong Kyu
    Kim, Soochong
    Hyun, Sang-Hwan
    Park, Young Seok
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2020, 63 (05) : 579 - 589
  • [26] Adenosine A2A receptors modulate BDNF both in normal conditions and in experimental models of Huntington's disease
    Potenza, R. L.
    Tebano, M. T.
    Martire, A.
    Domenici, M. R.
    Pepponi, R.
    Armida, M.
    Pezzola, A.
    Minghetti, L.
    Popoli, P.
    PURINERGIC SIGNALLING, 2007, 3 (04) : 333 - 338
  • [27] Adenosine A2A receptors modulate BDNF both in normal conditions and in experimental models of Huntington’s disease
    R. L. Potenza
    M. T. Tebano
    A. Martire
    M. R. Domenici
    R. Pepponi
    M. Armida
    A. Pèzzola
    L. Minghetti
    P. Popoli
    Purinergic Signalling, 2007, 3 : 333 - 338
  • [28] Primed and nonprimed human embryonic stem cell-derived neural precursor transplantation into the quinolinic acid lesion rodent model of Huntington's disease
    Vazey, E. M.
    Dottori, M.
    Jamshidi, P.
    Pera, M. F.
    Horne, M.
    Connor, B.
    CELL TRANSPLANTATION, 2008, 17 (04) : 484 - 485
  • [29] Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease
    Hughes, PE
    Alexi, T
    Williams, CE
    Clark, RG
    Gluckman, PD
    NEUROSCIENCE, 1999, 92 (01) : 197 - 209
  • [30] ALTERATIONS OF BRAIN NEUROTRANSMITTERS AND METABOLITES IN A RAT MODEL OF HUNTINGTON'S DISEASE
    Kumar, A.
    Gandhi, A.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 70 - 71
12345